Since oxidative phosphorylation is impaired in RCC [20], co-activation of the Nrf2 pathway and the PI3K/Akt/mTOR pathway might cooperatively cause a shift of metabolism to aerobic glycolysis that enhances tumor cell growth. The gene discussed is AKT1; the disease is renal cell carcinoma.